Morbillivirus vaccines: Recent successes and future hopes

Vaccine

Volumn 32, Issue 26, 2014, Pages 3155-3161

  Buczkowski, Hubert ^a   Muniraju, Murali ^b   Parida, Satya ^b   Banyard, Ashley C ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

Canine distemper; Eradication; Measles; Morbillivirus; Peste des petits ruminants; Rinerpest; Vaccines

Indexed keywords

MEASLES VACCINE;

CANINE DISTEMPER MORBILLIVIRUS; CATTLE PLAGUE VIRUS; MEASLES VIRUS; PRIORITY JOURNAL; REVIEW; VACCINATION; VIRAL CLEARANCE;

CANINE DISTEMPER; ERADICATION; MEASLES; MORBILLIVIRUS; PESTE DES PETITS RUMINANTS; RINERPEST; VACCINES;

ANIMALS; DISTEMPER VIRUS, CANINE; DOGS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MEASLES VIRUS; MORBILLIVIRUS; MORBILLIVIRUS INFECTIONS; PESTE-DES-PETITS-RUMINANTS VIRUS; RINDERPEST VIRUS; RUMINANTS; VACCINATION; VACCINES, ATTENUATED; VACCINES, DNA; VIRAL VACCINES;

EID: 84900436435     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.03.053     Document Type: Review

References (111)

1. Scott G.R. The Murrain now known as Rinderpest. Newsl Trop Agr Assoc UK 2000, (20):14-16.
2. Furuse Y., Suzuki A., Oshitani H. Origin of measles virus: divergence from rinderpest virus between the 11th and 12th centuries. Virol J 2010, 7:52. [Epub: 2010/03/06].
3. Roeder P.L. Rinderpest: the end of cattle plague. Prevent Vet Med 2011, 102(2):98-106. [Epub: 2011/07/26].
4. Taylor W.P., Roeder P.L., Rweyemamu M.M. History of vaccines and vaccination. Rinderpest and Peste des Petits Ruminants. Virus Plagues of Large and Small Ruminants 2006, 222-247. Academic Press. T. Barrett, P.-P. Pastoret, W.P. Taylor (Eds.).
5. Brown R.D., Raschid A. The duration of immunity following vaccination with caprinised virus in the field. Annual Report 1958, 21. East African Veterinary Research Organisation, 1956-57.
6. Edwards J.T. The uses and limitations of the caprinised virus in the control of rinderpest (cattle plague) among British and Near-Eastern cattle. Br Vet J 1949, 105:209-253.
7. Nakamura J., Fukusho K., Kuroda S. Rinderpest: laboratory experiments on immunisation of Chosen cattle by simultaneous inoculation with immune serum and rabbit virus. Jpn J Vet Sci 1943, 5:455-477. [abstracted in Vet Bull 22 (1944) 186-187].
8. Johnson R.H. Rinderpest in tissue culture. I: Methods for virus production. Br Vet J 1962, 118:107-116.
9. Plowright W., Ferris R.D. Studies with rinderpest virus in tissue culture. I. Growth and cytopathogenicity. J Comp Pathol 1959, 69(2):152-172. [Epub: 1959/04/01].
10. Plowright W. The application of monolayer tissue culture techniques in rinderpest research. II. The use of attenuated culture virus as a vaccine for cattle. Bull Off Int Epizoot 1962, 57(253-276).
11. Walsh E.P., Baron M.D., Anderson J., Barrett T. Development of a genetically marked recombinant rinderpest vaccine expressing green fluorescent protein. J Gen Virol 2000, 81(Pt. 3):709-718. [Epub: 2000/02/17].
12. Parida S., Mahapatra M., Kumar S., Das S.C., Baron M.D., Anderson J., et al. Rescue of a chimeric rinderpest virus with the nucleocapsid protein derived from peste-des-petits-ruminants virus: use as a marker vaccine. J Gen Virol 2007, 88(Pt. 7):2019-2027. [Epub: 2007/06/08].
13. Buczkowski H., Parida S., Bailey D., Barrett T., Banyard A.C. A novel approach to generating morbillivirus vaccines: negatively marking the rinderpest vaccine. Vaccine 2012, 30(11):1927-1935. [Epub: 2012/01/24].
14. FAO Report of the FAO Expert Consultation on the Strategy for Global Rinderpest Eradication. Held at FAO Headquarters, Rome, 27-29 October 1992 1992, FAO, Rome.
15. Rweyemamu M.M., Cheneau Y. Strategy for the global rinderpest eradication programme. Vet Microbiol 1995, 44(2-4):369-376. [Epub: 1995/05/01].
16. Normile D. Animal science. Rinderpest, deadly for cattle, joins smallpox as a vanquished disease. Science 2010, 330(6003):435. [Epub: 2010/10/23].
17. Enders J.F., Peebles T.C. Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc Soc Exp Biol Med Soc Exp Biol Med 1954, 86(2):277-286. [Epub: 1954/06/01].
18. Enders J.F., Peebles T.C., McCarthy K., Milovanovic M., Mitus A., Holloway A. Measles virus: a summary of experiments concerned with isolation, properties, and behavior. Am J Publ Health Nation's Health 1957, 47(3):275-282. [Epub: 1957/03/01].
19. Katz S.L., Enders J.F., Holloway A. The development and evaluation of an attenuated measles virus vaccine. Am J Publ Health Nation's Health 1962, 52(2 Suppl.):5-10. [Epub: 1962/02/01].
20. Karelitz S., Peck F.B. Experience with measles immunization. Alum-absorbed killed measles-virus vaccine and live measles-virus vaccine challenge. Am J Dis Child 1962, 103:427-429. [Epub: 1962/03/01].
21. Rauh L.W., Schmidt R. Measles immunization with killed virus vaccine. Serum antibody titers and experience with exposure to measles epidemic. Am J Dis Child 1965, 109:232-237. [Epub: 1965/03/01].
22. Hilleman M.R., Buynak E.B., Weibel R.E., Stokes J., Whitman J.E., Leagus M.B. Development and evaluation of the Moraten measles virus vaccine. JAMA 1968, 206(3):587-590. [Epub: 1968/10/14].
23. Stokes J., Weibel R.E., Villarejos V.M., Arguedas J.A., Buynak E.B., Hilleman M.R. Trivalent combined measles-mumps-rubella vaccine. Findings in clinical-laboratory studies. JAMA 1971, 218(1):57-61. [Epub: 1971/10/04].
24. Banatvala J.E., Brown D.W. Rubella Lancet 2004, 363(9415):1127-1137. [Epub: 2004/04/06].
25. Gay N.J. The theory of measles elimination: implications for the design of elimination strategies. J Infect Dis 2004, 189(Suppl. 1):S27-S35. [Epub: 2004/04/24].
26. Wakefield A.J., Murch S.H., Anthony A., Linnell J., Casson D.M., Malik M., et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998, 351(9103):637-641. [Epub: 1998/03/21].
27. Black C., Kaye J.A., Jick H. Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database. BMJ 2002, 325(7361):419-421. [Epub: 2002/08/24].
28. Uno Y., Uchiyama T., Kurosawa M., Aleksic B., Ozaki N. The combined measles, mumps, and rubella vaccines and the total number of vaccines are not associated with development of autism spectrum disorder: the first case-control study in Asia. Vaccine 2012, 30(28):4292-4298. [Epub: 2012/04/24].
29. Retraction-ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 2010, 375(9713):445. [Epub: 2010/02/09].
30. Jansen V.A., Stollenwerk N., Jensen H.J., Ramsay M.E., Edmunds W.J., Rhodes C.J. Measles outbreaks in a population with declining vaccine uptake. Science 2003, 301(5634):804. [Epub: 2003/08/09].
31. Casiday R., Cresswell T., Wilson D., Panter-Brick C. A survey of UK parental attitudes to the MMR vaccine and trust in medical authority. Vaccine 2006, 24(2):177-184. [Epub: 2005/09/15].
32. Pearce A., Law C., Elliman D., Cole T.J., Bedford H. Factors associated with uptake of measles, mumps, and rubella vaccine (MMR) and use of single antigen vaccines in a contemporary UK cohort: prospective cohort study. BMJ 2008, 336(7647):754-757. Millennium Cohort Study Child Health G, [Epub: 2008/03/04].
33. WHO WHO Epidemiological Brief 2011, vol. 18:1-6.
34. http://www.hpa.org.uk/cdr/archives/2003/cdr3903.pdf.
35. White J.M., Rush M., Leon S., Ramsay M.E. COVER/Korner 95-1 (April to June 1995). Vaccination Coverage Statistics for Children up to 2 Years Old in the United Kingdom. Communicable Disease Report CDR Review 1995, vol. 5(12):R186-R187. [Epub: 1995/11/10].
36. Muscat M., Bang H., Wohlfahrt J., Glismann S., Molbak K., Group E.N. Measles in Europe: an epidemiological assessment. Lancet 2009, 373(9661):383-389. [Epub: 2009/01/10].
37. Tamin A., Rota P.A., Wang Z.D., Heath J.L., Anderson L.J., Bellini W.J. Antigenic analysis of current wild type and vaccine strains of measles virus. J Infect Dis 1994, 170(4):795-801. [Epub: 1994/10/01].
38. Billeter M.A., Naim H.Y., Udem S.A. Reverse genetics of measles virus and resulting multivalent recombinant vaccines: applications of recombinant measles viruses. Curr Top Microbiol Immunol 2009, 329:129-162. [Epub: 2009/02/10].
39. Yoneda M., Georges-Courbot M.C., Ikeda F., Ishii M., Nagata N., Jacquot F., et al. Recombinant measles virus vaccine expressing the nipah virus glycoprotein protects against lethal nipah virus challenge. PloS ONE 2013, 8(3):e58414. [Epub: 2013/03/22].
40. Reyes-del Valle J., de la Fuente C., Turner M.A., Springfeld C., Apte-Sengupta S., Frenzke M.E., et al. Broadly neutralizing immune responses against hepatitis C virus induced by vectored measles viruses and a recombinant envelope protein booster. J Virol 2012, 86(21):11558-11566. [Epub: 2012/08/17].
41. Stebbings R., Fevrier M., Li B., Lorin C., Koutsoukos M., Mee E., et al. Immunogenicity of a recombinant measles-HIV-1 clade B candidate vaccine. PloS ONE 2012, 7(11):e50397. [Epub: 2012/12/12].
42. Brandler S., Marianneau P., Loth P., Lacote S., Combredet C., Frenkiel M.P., et al. Measles vaccine expressing the secreted form of West Nile virus envelope glycoprotein induces protective immunity in squirrel monkeys, a new model of West Nile virus infection. J Infect Dis 2012, 206(2):212-219. [Epub: 2012/05/04].
43. Brandler S., Ruffie C., Najburg V., Frenkiel M.P., Bedouelle H., Despres P., et al. Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses. Vaccine 2010, 28(41):6730-6739. [Epub: 2010/08/07].
44. Reyes-del Valle J., Hodge G., McChesney M.B., Cattaneo R. Protective anti-hepatitis B virus responses in rhesus monkeys primed with a vectored measles virus and boosted with a single dose of hepatitis B surface antigen. J Virol 2009, 83(17):9013-9017. [Epub: 2009/06/19].
45. Liniger M., Zuniga A., Morin T.N., Combardiere B., Marty R., Wiegand M., et al. Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses. Vaccine 2009, 27(25-26):3299-3305. [Epub: 2009/02/10].
46. Rouxel R.N., Svitek N., von Messling V. A chimeric measles virus with canine distemper envelope protects ferrets from lethal distemper challenge. Vaccine 2009, 27(36):4961-4966. [Epub: 2009/06/23].
47. Liniger M., Zuniga A., Tamin A., Azzouz-Morin T.N., Knuchel M., Marty R.R., et al. Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses. Vaccine 2008, 26(17):2164-2174. [Epub: 2008/03/19].
48. Zuniga A., Wang Z., Liniger M., Hangartner L., Caballero M., Pavlovic J., et al. Attenuated measles virus as a vaccine vector. Vaccine 2007, 25(16):2974-2983. [Epub: 2007/02/17].
49. Rima B.K. Strategy for measles eradication. Rinderpest and Peste des Petits Ruminants Virus Plagues of Large and Small Ruminants 2006, 284-297. T. Barrett, P.-P. Pastoret, W.P. Taylor (Eds.).
50. Dine M.S., Hutchins S.S., Thomas A., Williams I., Bellini W.J., Redd S.C. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination. J Infect Dis 2004, 189(Suppl. 1):S123-S130. [Epub: 2004/04/24].
51. Bruning-Richardson A., Akerblom L., Klingeborn B., Anderson J. Improvement and development of rapid chromatographic strip-tests for the diagnosis of rinderpest and peste des petits ruminants viruses. J Virol Methods 2011, 174(1-2):42-46. [Epub: 2011/03/23].
52. Dallaire F., De Serres G., Tremblay F.W., Markowski F., Tipples G. Long-lasting measles outbreak affecting several unrelated networks of unvaccinated persons. J Infect Dis 2009, 200(10):1602-1605. [Epub: 2009/10/16].
53. Halsey N.A. Increased mortality after high-titre measles vaccines: too much of a good thing. Pediatr Infect Dis J 1993, 12:462-465.
54. Polack F.P., Lee S.H., Permar S., Manyara E., Nousari H.G., Jeng Y., et al. Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles. Nat Med 2000, 6(7):776-781. [Epub: 2000/07/11].
55. Premenko-Lanier M., Rota P.A., Rhodes G.H., Bellini W.J., McChesney M.B. Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody. J Infect Dis 2004, 189(11):2064-2071. [Epub: 2004/05/15].
56. Pasetti M.F., Ramirez K., Resendiz-Albor A., Ulmer J., Barry E.M., Levine M.M. Sindbis virus-based measles DNA vaccines protect cotton rats against respiratory measles: relevance of antibodies, mucosal and systemic antibody-secreting cells, memory B cells, and Th1-type cytokines as correlates of immunity. J Virol 2009, 83(6):2789-2794. [Epub: 2009/01/09].
57. Pan C.H., Greer C.E., Hauer D., Legg H.S., Lee E.Y., Bergen M.J., et al. A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles. J Virol 2010, 84(8):3798-3807. [Epub: 2010/02/05].
58. Skiadopoulos M.H., Surman S.R., Riggs J.M., Collins P.L., Murphy B.R. A chimeric human-bovine parainfluenza virus type 3 expressing measles virus hemagglutinin is attenuated for replication but is still immunogenic in rhesus monkeys. J Virol 2001, 75(21):10498-10504. [Epub: 2001/10/03].
59. Blancou J. Dog distemper: imported into Europe from South America?. Hist Med Vet 2004, 29(2):35-41. [Epub: 2004/09/21].
60. Appel M.J., Summers B.A. Pathogenicity of morbilliviruses for terrestrial carnivores. Vet Microbiol 1995, 44(2-4):187-191. [Epub: 1995/05/01].
61. Woolf A., Gremillion-Smith C., Evans R.H. Evidence of canine distemper virus infection in skunks negative for antibody against rabies virus. J Am Vet Med Assoc 1986, 189(9):1086-1088. [Epub: 1986/11/01].
62. Osterhaus A.D., Groen J., De Vries P., UytdeHaag F.G., Klingeborn B., Zarnke R. Canine distemper virus in seals. Nature 1988, 335(6189):403-404. [Epub: 1988/09/29].
63. Harder T.C., Kenter M., Vos H., Siebelink K., Huisman W., van Amerongen G., et al. Canine distemper virus from diseased large felids: biological properties and phylogenetic relationships. J Gen Virol 1996, 77(Pt 3):397-405. [Epub: 1996/03/01].
64. Roelke-Parker M.E., Munson L., Packer C., Kock R., Cleaveland S., Carpenter M., et al. A canine distemper virus epidemic in Serengeti lions (Panthera leo). Nature 1996, 379(6564):441-445. [Epub: 1996/02/01].
65. Haas L., Hofer H., East M., Wohlsein P., Liess B., Barrett T. Canine distemper virus infection in Serengeti spotted hyenas. Vet Microbiol 1996, 49(1-2):147-152. [Epub: 1996/03/01].
66. van de Bildt M.W., Kuiken T., Visee A.M., Lema S., Fitzjohn T.R., Osterhaus A.D. Distemper outbreak and its effect on African wild dog conservation. Emerg Infect Dis 2002, 8(2):211-213. [Epub: 2002/03/19].
67. Thomas S. Canine distemper outbreak in ferrets in the UK. Vet Rec 2012, 170(1):27. [Epub: 2012/01/10].
68. Schumaker B.A., Miller M.M., Grosdidier P., Cavender J.L., Montgomery D.L., Cornish T.E., et al. Canine distemper outbreak in pet store puppies linked to a high-volume dog breeder. J Vet Diagn Invest 2012, 24(6):1094-1098. [Epub: 2012/09/27].
69. Nagao Y., Nishio Y., Shiomoda H., Tamaru S., Shimojima M., Goto M., et al. An outbreak of canine distemper virus in tigers (Panthera tigris): possible transmission from wild animals to zoo animals. J Vet Med Sci 2012, 74(6):699-705. [Epub: 2012/01/05].
70. Sakai K., Nagata N., Ami Y., Seki F., Suzaki Y., Iwata-Yoshikawa N., et al. Lethal canine distemper virus outbreak in cynomolgus monkeys in Japan in 2008. J Virol 2013, 87(2):1105-1114. [Epub: 2012/11/09].
71. Qiu W., Zheng Y., Zhang S., Fan Q., Liu H., Zhang F., et al. Canine distemper outbreak in rhesus monkeys, China. Emerg Infect Dis 2011, 17(8):1541-1543. [Epub: 2011/08/02].
72. Yoshikawa Y., Ochikubo F., Matsubara Y., Tsuruoka H., Ishii M., Shirota K., et al. Natural infection with canine distemper virus in a Japanese monkey (Macaca fuscata). Vet Microbiol 1989, 20(3):193-205. [Epub: 1989/07/01].
73. Haig D.A. Canine distemper-immunization with avianised virus. Onderstepoort J Vet Res 1956, 27:19-53.
74. Rockborn G. An attenuated strain of canine distemper virus in tissue culture. Nature 1959, 184(Suppl. 11):822. [Epub: 1959/09/12].
75. Hartley W.J. A post-vaccinal inclusion body encephalitis in dogs. Vet Pathol 1974, 11(4):301-312. [Epub: 1974/01/01].
76. Halbrooks R.D., Swango L.J., Schnurrenberger P.R., Mitchell F.E., Hill E.P. Response of gray foxes to modified live-virus canine distemper vaccines. J Am Vet Med Assoc 1981, 179(11):1170-1174. [Epub: 1981/12/01].
77. Carpenter J.W., Appel M.J., Erickson R.C., Novilla M.N. Fatal vaccine-induced canine distemper virus infection in black-footed ferrets. J Am Vet Med Assoc 1976, 169(9):961-964. [Epub: 1976/11/01].
78. Sutherland-Smith M.R., Rideout B.A., Mikolon A.B., Appel M.J., Morris P.J., Shima A.L., et al. Vaccine-induced canine distemper in European mink, Mustela lutreola. J Zoo Wildl Med Off Publ Am Assoc Zoo Vet 1997, 28(3):312-318. [Epub: 1997/11/20].
79. McInnes E.F., Burroughs R.E., Duncan N.M. Possible vaccine-induced canine distemper in a South American bush dog (Speothos venaticus). J Wildl Dis 1992, 28(4):614-617. [Epub: 1992/10/01].
80. Thomas-Baker B. Vaccination-induced distemper in maned wolves, vaccination-induced corneal opacity in a maned wolf. Proc Am Assoc Zoo Vet 1985, 53. [Ann. Rep., Scottsdale, Ariz.].
81. Montali R.J., Bartz C.R., Bush M. Canine distemper virus. Virus Infections of Carnivores 1987, 437-443. Elsevier Science Publishers, Amsterdam. M. Appel (Ed.).
82. Stephensen C.B., Welter J., Thaker S.R., Taylor J., Tartaglia J., Paoletti E. Canine distemper virus (CDV) infection of ferrets as a model for testing Morbillivirus vaccine strategies: NYVAC- and ALVAC-based CDV recombinants protect against symptomatic infection. J Virol 1997, 71(2):1506-1513. [Epub: 1997/02/01].
83. Coke R.L., Backues K.A., Hoover J.P., Saliki J.T., Ritchey J.W., West G.D. Serologic responses after vaccination of fennec foxes (Vulpes zerda) and meerkats (Suricata suricatta) with a live, canarypox-vectored canine distemper virus vaccine. J Zoo Wildl Med Off Publ Am Assoc Zoo Vet 2005, 36(2):326-330. [Epub: 2007/02/28].
84. Bronson E., Deem S.L., Sanchez C., Murray S. Serologic response to a canarypox-vectored canine distemper virus vaccine in the giant panda (Ailuropoda melanoleuca). J Zoo Wildl Med Off Publ Am Assoc Zoo Vet 2007, 38(2):363-366. [Epub: 2007/08/08].
85. Wimsatt J., Biggins D., Innes K., Taylor B., Garell D. Evaluation of oral and subcutaneous delivery of an experimental canarypox recombinant canine distemper vaccine in the Siberian polecat (Mustela eversmanni). J Zoo Wildl Med Off Publ Am Assoc Zoo Vet 2003, 34(1):25-35. [Epub: 2003/05/02].
86. Schultz R.D. Duration of immunity for canine and feline vaccines: a review. Vet Microbiol 2006, 117(1):75-79. [Epub: 2006/05/19].
87. Pardo M.C., Tanner P., Bauman J., Silver K., Fischer L. Immunization of puppies in the presence of maternally derived antibodies against canine distemper virus. J Compar Pathol 2007, 137(Suppl 1):S72-S75. [Epub: 2007/06/15].
88. Silin D., Lyubomska O., Ludlow M., Duprex W.P., Rima B.K. Development of a challenge-protective vaccine concept by modification of the viral RNA-dependent RNA polymerase of canine distemper virus. J Virol 2007, 81(24):13649-13658. [Epub: 2007/09/28].
89. Brown D.D., Rima B.K., Allen I.V., Baron M.D., Banyard A.C., Barrett T., et al. Rational attenuation of a morbillivirus by modulating the activity of the RNA-dependent RNA polymerase. J Virol 2005, 79(22):14330-14338. [Epub: 2005/10/29].
90. Sawatsky B., von Messling V. Canine distemper viruses expressing a hemagglutinin without N-glycans lose virulence but retain immunosuppression. J Virol 2010, 84(6):2753-2761. [Epub: 2010/01/01].
91. Jensen T.H., Nielsen L., Aasted B., Blixenkrone-Moller M. Early life DNA vaccination with the H gene of Canine distemper virus induces robust protection against distemper. Vaccine 2009, 27(38):5178-5183. [Epub: 2009/07/15].
92. Nielsen L., Jensen T.H., Kristensen B., Jensen T.D., Karlskov-Mortensen P., Lund M., et al. DNA vaccines encoding proteins from wild-type and attenuated canine distemper virus protect equally well against wild-type virus challenge. Acta Virol 2012, 157(10):1887-1896. [Epub: 2012/06/21].
93. Wang X., Feng N., Ge J., Shuai L., Peng L., Gao Y., et al. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper. Vaccine 2012, 30(34):5067-5072. [Epub: 2012/06/16].
94. Gargadennec L., Lalanne A. La peste des petits ruminants. Bull Serv Zootech Epiz Afr Occid Franc 1942, (5):16-21.
95. Gibbs E.P.J., Taylor W.P., Lawman M.P.J., Bryant J. Classification of peste des petits ruminants virus as the fourth member of the genus morbillivirus. Intervirology 1979, 11:268-274.
96. Dhar P., Sreenivasa B.P., Barrett T., Corteyn M., Singh R.P., Bandyopadhyay S.K. Recent epidemiology of peste des petits ruminants virus (PPRV). Vet Microbiol 2002, 88(2):153-159.
97. Taylor W.P. Protection of goats against peste-des-petits-ruminants with attenuated rinderpest virus. Res Vet Sci 1979, 27(3):321-324. [Epub: 1979/11/01].
98. Diallo A., Taylor W.P., Lefevre P.C., Provost A. Attenuation of a strain of rinderpest virus: potential homologous live vaccine. Revue d'elevage et de medecine veterinaire des pays tropicaux 1989, 42(3):311-319. [Epub: 1989/01/01, Attenuation d'une souche de virus de la peste des petits ruminants: candidat pour un vaccin homologue vivant].
99. Saravanan P., Sen A., Balamurugan V., Rajak K.K., Bhanuprakash V., Palaniswami K.S., et al. Comparative efficacy of peste des petits ruminants (PPR) vaccines. Biol J Int Assoc Biol Standard 2010, 38(4):479-485. [Epub: 2010/03/05].
100. Hu Q., Chen W., Huang K., Baron M.D., Bu Z. Rescue of recombinant peste des petits ruminants virus: creation of a GFP-expressing virus and application in rapid virus neutralization test. Vet Res 2012, 43(1):48. [Epub: 2012/06/05].
101. Muniraju M., Buczkowski H., Banyard A.C., Parida S. Development of a reverse genetics system for Peste des petits ruminants virus: the first successful rescue of a recombinant PPRV. 1st Meeting of the Global PPRV Eradication Alliance 2012.
102. Das S.C., Baron M.D., Barrett T. Recovery and characterization of a chimeric rinderpest virus with the glycoproteins of peste-des-petits-ruminants virus: homologous F and H proteins are required for virus viability. J Virol 2000, 74(19):9039-9047.
103. Anderson J., McKay J.A. The detection of antibodies against peste des petits ruminants virus in cattle, sheep and goats and the possible implications to rinderpest control programmes. Epidemiol Infect 1994, 112(1):225-231.
104. Berhe G., Minet C., Le Goff C., Barrett T., Ngangnou A., Grillet C., et al. Development of a dual recombinant vaccine to protect small ruminants against peste-des-petits-ruminants virus and capripoxvirus infections. J Virol 2003, 77(2):1571-1577. [Epub: 2002/12/28].
105. Diallo A., Minet C., Berhe G., Le Goff C., Black D.N., Fleming M., et al. Goat immune response to capripox vaccine expressing the hemagglutinin protein of peste des petits ruminants. Ann N Y Acad Sci 2002, 969:88-91. [Epub: 2002/10/17].
106. Chen W., Hu S., Qu L., Hu Q., Zhang Q., Zhi H., et al. A goat poxvirus-vectored peste-des-petits-ruminants vaccine induces long-lasting neutralization antibody to high levels in goats and sheep. Vaccine 2010, 28(30):4742-4750. [Epub: 2010/05/18].
107. Kock R.A., Wambua J.M., Mwanzia J., Wamwayi H., Ndungu E.K., Barrett T., et al. Rinderpest epidemic in wild ruminants in Kenya 1993-97. Vet Rec 1999, 145(10):275-283. [Epub: 1999/12/01].
108. Kinne J., Kreutzer R., Kreutzer M., Wernery U., Wohlsein P. Peste des petits ruminants in Arabian wildlife. Epidemiol Infect 2010, 138(8):1211-1214. [Epub: 2010/01/14].
109. Furley C.W., Taylor W.P., Obi T.U. An outbreak of peste des petits ruminants in a zoological collection. Vet Rec 1987, 121(19):443-447. [Epub: 1987/11/07].
110. Elzein E.M., Housawi F.M., Bashareek Y., Gameel A.A., Al-Afaleq A.I., Anderson E. Severe PPR infection in gazelles kept under semi-free range conditions. J Vet Med B Infect Dis Vet Publ Health 2004, 51(2):68-71. [Epub: 2004/03/20].
111. Woo P.C., Lau S.K., Wong B.H., Fan R.Y., Wong A.Y., Zhang A.J., et al. Feline morbillivirus, a previously undescribed paramyxovirus associated with tubulointerstitial nephritis in domestic cats. Proc Natl Acad Sci U S A 2012, 109(14):5435-5440. [Epub: 2012/03/21].